Ben Travis, PHD

Chief Executive Officer

Dr. Benjamin Travis is the Chief Executive Officer of CalibreScientific®, and Anatrace Products. After Anatrace was acquired by StoneCalibre in 2013, Ben has assisted StoneCalibre with technical aspects of Life Sciences M&A and has seen the business through five successful transactions since then: Edge BioSystems (2014), Microlytic (2015), Concise Separations (2015), Molecular Dimensions (2017), and Alpha-Tec Systems (2017).

Ben has over 20 years of experience in the life sciences industry. He has worked effectively in both technical and leadership positions and his management style and skills allow him to work cross-functionally between all branches of the organization. At Affymetrix, as the Life Science Reagents R&D Director, Ben was frequently the face and voice of company products for customers across both the USB and Anatrace brands. In this role, he developed the ability to convey technical information to experts and non-experts alike, and translate customer input and scientific trends into new, exciting, viable products.

Ben has developed two patents, authored 15 publications, and has created and conducted numerous presentations at various summits and symposiums across the United States.

Mike Drury

Chief Financial Officer

As the Chief Financial Officer for CalibreScientific®, Mike brings with him over 14 years of CFO/VP experience to the team. In Mike’s previous role he served as the President of Portfolio Operations at StoneCalibre and was responsible for the evaluation of new acquisition opportunities and overseeing the portfolio operations. Prior to that experience Mike Served as the CFO of Source Technologies, also a StoneCalibre portfolio company and over 16 years at General Electric.

Mike earned his MBA from the Weatherhead School of Management at Case Western Reserve University and his B.B.A in Accounting from Cleveland State University.  Mike is a Certified Public Accountant.

Brice Geoffrion

Director of Business Development

Brice joined CalibreScientific® in January of 2018 as the Director of Business Development, tasked with identifying new M&A opportunities and driving business development efforts in the Life Sciences and Healthcare industries. Brice is also an Associate with StoneCalibre, the private investment firm that backs CalibreScientific.

Prior to joining StoneCalibre, Brice worked for an insurance brokerage firm that specialized in placement for private equity groups. He earned his BS in Finance from the University of Alabama in Huntsville.

Mike Irwin

Senior Vice President, Sales

As the Senior Vice President of Sales, Mike’s fields of expertise have evolved from chromatography to general molecular biology and on to RT-PCR, microarrays, NGS, cytogenetics, and now proteins and structure. He has met all operational requirements needed for both entrepreneurial and large company roles, driving accountability and creativity with structures, channels, forecasts, budgets, CRM, and campaigning.

Mike has been successfully leading sales and business development with an active, hands-on touch for 25 years at Bio-Rad, ABI/LifeTech, PacBio, Agilent, and RainDance. He has managed large operational initiatives, like going to a direct channel business in Brazil, and turned over both Agilent’s and RainDance’s lists of top sold-to companies from a handful of key academics to a diverse group containing many more key biopharma and Dx firms. At PacBio, as director of business development, Mike was one of the first three commercial leaders that launched the RS platform, which hit its first-year target of $40M in sales.

Mike has put feet on the street, held P&L, and managed sales, support, and field marketing for up to $150M of business in the Americas, and has extensive ties with EMEA and APAC partners.

Matthew Lorence, PhD, MBA

Senior Vice President, Marketing

Dr. Matthew Lorence is Senior Vice President of Marketing for CalibreScientific®, and President and CEO of Edge Biosystems, a portfolio company of CalibreScientific®. He has extensive experience in genomic technologies, including NGS and Sanger sequencing, RT-PCR, and microarrays, with broad knowledge of the CLIA regulations related to the development of LDTs based on these technologies.

Matt has more than 20 years of experience in the molecular diagnostic, genomics, and life science tools industries, from start-up to highly-matrixed organizations, with a track record of growing existing businesses, building new businesses, and developing strategies to enter new markets. Matt has also served as Senior Vice-President of Marketing and Business Development for TessArae, LLC, and Associate Director of Business Development for biodefense, infectious disease, and all other microbiology applications at Affymetrix.

Matt has authored 20 publications in peer-reviewed journals and given technical and commercial presentations at numerous international conferences and symposia. In addition to his commercial activities, Matt is a member of the Steering Committee for the ATCC Standards Development Organization, a Subject Matter Expert for the B.Next program at In-Q-Tel, and an External Grant Reviewer for Grand Challenges Canada.

Mike Brownleader, PHD

Director of European Operations and Sales

Dr. Mike Brownleader is the Director of European Operations and Sales and CEO of BioservUK, Protein Ark and OEEEY. As a protein biochemist with more than two decades of experience in the life sciences market, Brownleader has also had 25 peer-reviewed articles published in international journals.  Attracting more than £1M research awards from national funding agencies, Brownleader was awarded the prestigious Special Research Fellowship of The Leverhulme Trust for research.

Prior to BioServ, Protein Ark and OEEEY, Brownleader worked as R & D  Applications Manager at Sartorius Lab Ltd.,  a leading global provider of innovative, low-to-high throughput sample preparation tools and solutions for the research product and clinical diagnostic arenas. In 2001, he founded Generon Ltd, a UK distributor of protein sample preparation kits, services and reagents to the biolab market. His role included the active management of the UK field and internal sales team targeting pharma, biotech, universities, research institutes and hospitals.

In 2014, Brownleader founded Protein Ark Ltd., an R & D and applications-focused life science consumable company offering a comprehensive range of sample preparation and protein separation kits and custom services for the clinical diagnostic and drug discovery research markets. He purchased BioservUK Ltd., a CRO/CMO company offering de novo and bulk manufacturing of custom antibodies, recombinant proteins and peptides for the IVD market. Together with OEEEY Ltd., a company offering innovative knowledge management and big data mining software for biomedical and life scientists, all three businesses were sold to CalibreScientific® in Spring of 2018.

Brownleader remains an honorary lecturer in the Department of Pharmaceutical and Biological Chemistry at UCL.